Vladimir Avkshtol

Fox Chase Cancer Center

Papers

1

Total Citations

28

H-Index

1

About

Dr. Vladimir Avkshtol is a radiation oncologist whose research centers on advancing stereotactic body radiation therapy (SBRT) for prostate cancer, with a focus on comparing treatment delivery technologies. His most cited work, a 2016 study comparing robotic arm versus gantry linear accelerator SBRT, established critical benchmarks for precision and efficacy in prostate cancer treatment—a disease that remains the most common non-skin cancer in American men. This paper, with 28 citations, has helped shape clinical decision-making by evaluating how different platforms affect treatment outcomes and patient safety. Dr. Avkshtol’s contributions extend to optimizing fractionation schedules and reducing toxicity, directly improving the therapeutic ratio for patients undergoing SBRT. His research underscores the importance of technological innovation in radiation oncology, offering practical insights for clinicians adopting advanced delivery systems. By systematically comparing these approaches, he has provided evidence that supports the growing use of SBRT as a convenient, five-fraction regimen, ultimately enhancing quality of life for prostate cancer patients.

Research Focus

Key Achievements

1
H-Index
1
Papers
28
Total Citations
28
Avg Citations/Paper
🏆 Most Cited Paper
A comparison of robotic arm versus gantry linear accelerator stereotactic body radiation therapy for prostate cancer
28 citations · 2016
📈 Most Prolific Year: 2016 (1 Papers)
🤝 Key Collaborators: 7
🏛 Institutions: Fox Chase Cancer Center

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago